Abstract
国家卫生健康委员会针对新型冠状病毒肺炎（COVID-19）疫情先后组织专家制定了6版诊疗方案，其中推荐于重型和危重型患者使用中药注射剂。本文基于中医药理论，从临床合理用药的角度分析了第六版方案推荐的中药注射剂的特点，认为COVID-19重型和危重型病机以血瘀为基础，疫毒炽盛进而导致闭证和脱证同时并现，提出：重型疫毒闭肺证可使用喜炎平注射液；重型气营两燔证可使用痰热清注射液和热毒宁注射液；危重型内闭外脱证使用参附注射液、生脉注射液或参麦注射液固脱，但必须与苏合香丸、安宫牛黄丸或醒脑静注射液开窍合用，且须辨明阴阳，阳脱者使用参附注射液，阴脱者使用生脉注射液，阳闭者使用醒脑静注射液；血瘀证是重型和危重型的共有病机，应选用血必净注射液等改善微循环，保证各组织器官充分灌流，为调动人体抗病潜能，截断扭转病势奠定基础。.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
